Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome

Reuben Matalon, Bradley Arbogast, Albert Dorfman

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

The Maroteaux-Lamy syndrome (Mucopolysaccharidosis VI) is characterized by excessive excretion in urine and deposition in tissue of dermatan sulfate. To investigate the enzymic basis of this disease [35S]chondroitin 4-sulfate was prepared utilizing a rat chondrosarcoma. Extracts of fibroblasts derived from patients with this syndrome showed a marked diminution of release of 35SO4 both from [35S]chondroitin 4-SO4 and from a heptasaccharide derived from this substance. Since there is a marked deficiency of arylsulfatase B activity in this disease, it is concluded that natural substrate of arylsulfatase B is N-acetylgalactosamine 4-SO4 in chondroitin 4-SO4 and dermatan sulfate.

Original languageEnglish (US)
Pages (from-to)1450-1457
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume61
Issue number4
DOIs
StatePublished - Dec 23 1974
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome'. Together they form a unique fingerprint.

  • Cite this